0001607062-21-000058.txt : 20210318
0001607062-21-000058.hdr.sgml : 20210318
20210318185658
ACCESSION NUMBER: 0001607062-21-000058
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210312
FILED AS OF DATE: 20210318
DATE AS OF CHANGE: 20210318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KIKIS THOMAS EVANGELOS
CENTRAL INDEX KEY: 0001749112
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55657
FILM NUMBER: 21755931
MAIL ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROPATHIX, INC.
CENTRAL INDEX KEY: 0001615999
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462645343
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
BUSINESS PHONE: 858-883-2642
MAIL ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
FORMER COMPANY:
FORMER CONFORMED NAME: Neuropathix, Inc.
DATE OF NAME CHANGE: 20201112
FORMER COMPANY:
FORMER CONFORMED NAME: Kannalife Inc
DATE OF NAME CHANGE: 20181113
FORMER COMPANY:
FORMER CONFORMED NAME: TYG Solutions Corp.
DATE OF NAME CHANGE: 20140821
4/A
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4/A
2021-03-12
2021-03-16
0
0001615999
NEUROPATHIX, INC.
NPTX
0001749112
KIKIS THOMAS EVANGELOS
3805 OLD EASTON ROAD
DOYLESTOWN
PA
18902
1
1
0
0
Chief Communication Officer
Employee Stock Option (Right to Buy)
0.13
2021-03-12
4
A
0
800000
0
A
2031-03-11
Common Stock
800000
800000
D
1/4th of the option shares vest on the date of grant and the remaining option shares vest in equal monthly installments over 36 months thereafter.
This Amendment No. 1 ("Form 4/A") to the Form 4 filed by the reporting person on March 16, 2021 is being filed to correct an administrative error, resulting in the incorrect expiration date being included for the options. As reflected in this Form 4/A, the correct expiration date for the options is March 11, 2031.
/s/ Thomas E. Kikis
2021-03-18